Watch how SLT (Selective Laser Trabeculoplasty), the recommended first-line therapy for glaucoma, gently reduces intraocular pressure (IOP). SLT acts at a cellular level to specifically trigger thermolysis of pigmented trabecular meshwork (TM) cells, the process of which stimulates the release of proteins and cytokines, and recruitment of macrophages. This restorative mechanism results in the improvement of aqueous humour circulation through the TM and the inner walls of Schlemm’s canal, thereby reducing IOP.

свернуть